Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Eur J Nutr. 2013 Oct 4;53(3):843–852. doi: 10.1007/s00394-013-0588-5

Fig. 1.

Fig. 1

SFN treatment causes induction of vimentin protein expression in prostate cancer cells. a Western blotting for vimentin and E-cadherin proteins using lysates from PC-3 and DU145 cells after treatment with DMSO (control) or the indicated concentrations of SFN for specified time periods. b Densitometric quantitation of vimentin and E-cadherin protein expression changes (arbitrary units) from western blots shown in panel a. Results shown are mean ± SD (n=2–3). Quantitation was normalized against actin protein band intensity for each individual experiment.